» Articles » PMID: 31301956

Tumour Hypoxia

Overview
Specialty Oncology
Date 2019 Jul 15
PMID 31301956
Citations 4
Authors
Affiliations
Soon will be listed here.
Citing Articles

Bacterial carrier-mediated drug delivery systems: a promising strategy in cancer therapy.

Yan S, Gan Y, Xu H, Piao H Front Bioeng Biotechnol. 2025; 12():1526612.

PMID: 39845371 PMC: 11750792. DOI: 10.3389/fbioe.2024.1526612.


Tumour response to hypoxia: understanding the hypoxic tumour microenvironment to improve treatment outcome in solid tumours.

Bigos K, Quiles C, Lunj S, Smith D, Krause M, Troost E Front Oncol. 2024; 14:1331355.

PMID: 38352889 PMC: 10861654. DOI: 10.3389/fonc.2024.1331355.


Current Status and Future Directions of Bacteria-Based Immunotherapy.

Tang Q, Peng X, Xu B, Zhou X, Chen J, Cheng L Front Immunol. 2022; 13:911783.

PMID: 35757741 PMC: 9226492. DOI: 10.3389/fimmu.2022.911783.


Innovative Approaches of Engineering Tumor-Targeting Bacteria with Different Therapeutic Payloads to Fight Cancer: A Smart Strategy of Disease Management.

Allemailem K Int J Nanomedicine. 2021; 16:8159-8184.

PMID: 34938075 PMC: 8687692. DOI: 10.2147/IJN.S338272.


Bacteria-Based Cancer Immunotherapy.

Huang X, Pan J, Xu F, Shao B, Wang Y, Guo X Adv Sci (Weinh). 2021; 8(7):2003572.

PMID: 33854892 PMC: 8025040. DOI: 10.1002/advs.202003572.